Fortis Healthcare Ltd

Fortis Healthcare Ltd

₹ 700 3.44%
03 Dec - close price
About

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1]

Company controls its diagnostics business through its 57% owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients and 1,400 Collection Centers. [2]

Key Points

Network[1]
Fortis operates 27 hospitals (including JVs) with ~4,500 operational beds, 5,500+ Doctors, 6,500+ Nurses and ~24,000 employees (including Agilus). 4 facilities are JCI accredited and 21 NABH Accredited.
**State-wise Beds Split - **
NCR - 1722
West Bengal - 335
Chattisgarh - 70
Karnataka - 620
Maharashtra - 770
Rajasthan - 275
Punjab - 774

  • Market Cap 52,796 Cr.
  • Current Price 700
  • High / Low 740 / 375
  • Stock P/E 76.8
  • Book Value 104
  • Dividend Yield 0.14 %
  • ROCE 10.3 %
  • ROE 7.85 %
  • Face Value 10.0

Pros

  • Company has delivered good profit growth of 42.8% CAGR over last 5 years

Cons

  • Stock is trading at 6.74 times its book value
  • Company has a low return on equity of 7.30% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
1,463 1,467 1,378 1,488 1,607 1,560 1,643 1,657 1,770 1,680 1,786 1,859 1,988
1,178 1,180 1,157 1,237 1,304 1,283 1,372 1,386 1,440 1,396 1,405 1,516 1,554
Operating Profit 284 287 221 251 303 276 271 272 330 284 381 343 435
OPM % 19% 20% 16% 17% 19% 18% 16% 16% 19% 17% 21% 18% 22%
13 20 13 31 75 26 26 10 18 19 17 14 -42
Interest 40 38 30 31 33 33 32 31 32 33 35 35 36
Depreciation 75 76 77 74 77 83 82 79 84 87 92 91 95
Profit before tax 182 193 126 176 268 186 183 171 233 183 271 230 261
Tax % 28% 27% 31% 24% 19% 24% 25% 27% 21% 27% 25% 24% 26%
131 142 87 134 218 142 138 124 184 134 203 174 193
EPS in Rs 1.42 1.55 0.90 1.62 2.71 1.72 1.76 1.48 2.30 1.78 2.37 2.20 2.34
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
3,042 3,492 3,966 4,199 4,574 4,561 4,469 4,632 4,030 5,718 6,298 6,893 7,313
3,827 3,430 3,857 4,106 4,220 4,287 4,238 4,022 3,626 4,649 5,196 5,625 5,870
Operating Profit -785 62 109 92 354 274 231 610 404 1,069 1,101 1,268 1,442
OPM % -26% 2% 3% 2% 8% 6% 5% 13% 10% 19% 17% 18% 20%
2,169 152 92 299 649 -689 228 126 95 367 157 64 8
Interest 461 250 152 133 229 258 337 205 166 147 129 131 139
Depreciation 229 183 235 225 222 239 233 292 291 301 316 342 365
Profit before tax 694 -219 -185 34 552 -912 -110 239 43 988 814 858 946
Tax % 25% 5% 2% -24% 13% 2% 103% 62% 230% 20% 22% 25%
528 -218 -130 42 479 -934 -224 91 -56 790 633 645 704
EPS in Rs 12.34 -4.73 -3.10 0.40 8.14 -19.46 -3.96 0.77 -1.45 7.35 7.80 7.93 8.69
Dividend Payout % 0% -0% -1% 0% 0% 0% 0% 0% 0% 0% 13% 13%
Compounded Sales Growth
10 Years: 7%
5 Years: 9%
3 Years: 20%
TTM: 10%
Compounded Profit Growth
10 Years: 17%
5 Years: 43%
3 Years: 136%
TTM: 30%
Stock Price CAGR
10 Years: 21%
5 Years: 38%
3 Years: 35%
1 Year: 81%
Return on Equity
10 Years: 3%
5 Years: 4%
3 Years: 7%
Last Year: 8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 405 463 463 463 518 519 755 755 755 755 755 755 755
Reserves 3,301 3,820 3,585 3,998 4,626 3,543 5,846 5,906 5,365 5,423 6,487 6,908 7,092
7,145 2,550 1,784 1,513 2,217 1,962 2,010 1,594 1,531 1,255 926 1,155 1,186
2,662 1,018 1,760 1,257 2,227 2,455 2,875 2,781 3,216 4,082 3,921 4,153 4,563
Total Liabilities 13,514 7,851 7,592 7,232 9,588 8,479 11,486 11,036 10,866 11,516 12,089 12,971 13,597
9,274 4,147 4,218 3,642 5,419 4,992 8,477 8,802 8,799 9,416 9,426 9,874 10,172
CWIP 244 147 228 226 268 226 450 204 165 193 228 542 435
Investments 1,187 1,817 1,464 1,452 1,878 1,732 270 175 186 104 210 230 175
2,808 1,739 1,682 1,913 2,023 1,529 2,290 1,856 1,716 1,803 2,225 2,326 2,814
Total Assets 13,514 7,851 7,592 7,232 9,588 8,479 11,486 11,036 10,866 11,516 12,089 12,971 13,597

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1,644 479 24 195 966 493 -179 172 485 865 822 1,100
-1,490 2,503 213 122 -1,001 -333 -3,279 63 -131 -501 -372 -889
-74 -3,217 -304 -354 259 -672 4,257 -862 -143 -517 -471 -86
Net Cash Flow 80 -235 -66 -37 225 -513 799 -627 212 -153 -21 125

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 80 46 38 39 38 38 44 36 41 33 34 33
Inventory Days 43 26 25 23 23 24 22 30 29 33 31 24
Days Payable 413 200 207 218 215 279 296 226 205 178 179 164
Cash Conversion Cycle -290 -128 -144 -156 -155 -217 -230 -161 -135 -112 -115 -107
Working Capital Days -133 -16 -69 -24 -33 -76 -133 -116 -37 -21 -12 -115
ROCE % 1% 0% -0% 3% 11% 3% 6% 4% 2% 10% 10% 10%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17%
30.08% 29.82% 29.66% 30.59% 31.01% 31.22% 30.03% 26.31% 23.72% 23.24% 23.31% 25.26%
15.67% 16.90% 17.60% 20.02% 20.38% 20.69% 22.17% 26.55% 29.42% 31.14% 32.31% 30.73%
23.08% 22.12% 21.57% 18.22% 17.44% 16.92% 16.65% 15.97% 15.71% 14.44% 13.22% 12.83%
No. of Shareholders 1,54,5721,56,8811,60,7621,58,4551,43,5191,37,8941,35,0471,31,5161,35,6641,57,1651,54,2602,04,184

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls